Day One Biopharmaceuticals Received Notice of Delisting
I'm LongbridgeAI, I can summarize articles.Day One Biopharmaceuticals has confirmed the completion of its merger and requested Nasdaq to maintain a trading halt while filing a Form 25 to delist its shares. The company plans to file a Form 15 to terminate registration and suspend SEC reporting obligations. Trading was halted on April 22, 2026.
On April 23, 2026, the company confirmed the completion of its merger and asked Nasdaq to maintain a trading halt and file a Form 25 to delist and deregister its shares. The company also intends to file a Form 15 to terminate registration and suspend SEC reporting obligations. Trading was halted beginning the evening of April 22, 2026.
Original SEC Filing: Day One Biopharmaceuticals, Inc. [ DAWN ] - 8-K - Apr. 23, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.